The effects of aspirin on platelet function and lysophosphatidic acids depend on plasma concentrations of EPA and DHA

This publication has 48 references indexed in Scilit:

• The effects of aspirin and fish oil consumption on lysophosphatidylcholines and lysophosphatidic acids and their correlates with platelet aggregation in adults with diabetes mellitus
  Prostaglandins, Leukotrienes and Essential Fatty Acids, 2013
• Effects of low-dose aspirin and fish oil on platelet function and NF-kappaB in adults with diabetes mellitus
  Prostaglandins, Leukotrienes and Essential Fatty Acids, 2013
• Comparison of Bleeding Complications With Omega-3 Fatty Acids + Aspirin + Clopidogrel—Versus—Aspirin + Clopidogrel in Patients With Cardiovascular Disease
  The American Journal of Cardiology, 2009
• Combination Antiplatelet Therapy for Secondary Stroke Prevention: Enhanced Efficacy or Double Trouble?
  The American Journal of Cardiology, 2009
• Safety Considerations with Omega-3 Fatty Acid Therapy
  The American Journal of Cardiology, 2007
• The Metabolic Syndrome, Circulating Oxidized LDL, and Risk of Myocardial Infarction in Well-Functioning Elderly People in the Health, Aging, and Body Composition Cohort
  Diabetes, 2004
• Definition of Metabolic Syndrome
  Circulation, 2004
• Free fatty acids and type 2 diabetes mellitus
  The American Journal of Medicine, 2003
• Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions
  Proceedings of the National Academy of Sciences, 1999
• Do fish oils prevent restenosis after coronary angioplasty?
  Circulation, 1994